Prognostic significance of p53 gene alterations in node-negative breast cancer (original) (raw)
References
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–53, 1991 Google Scholar
Linzer DIH, Levine AJ: Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43–52, 1979 Google Scholar
Eliyahu D, Raz A, Gruss P, Givol D, Oren M: Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312: 646–649, 1984 Google Scholar
Parada LF, Land H, Weinberg RA, Wolf D, Rotter V: Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312: 649–651, 1984 Google Scholar
Hinds P, Finlay C, Levine AJ: Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 63: 739–746, 1989 Google Scholar
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M: Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 86: 8763–8767, 1989 Google Scholar
Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912–915, 1990 Google Scholar
Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351: 453–456, 1991 Google Scholar
Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M: Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene 5: 137–145, 1990 Google Scholar
Milner J, Medcalf EA: Contranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65: 765–774, 1991 Google Scholar
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990 Google Scholar
Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S: Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88: 10657–10661, 1991 Google Scholar
Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa APM, Chiba I, Takahashi T, Nau MM, Callahan R, Minna JD: Mutations in the p53 gene in primary human breast cancers. Cancer Res 51: 6194–6198, 1991 Google Scholar
Prosser J, Thompson AM, Cranston G, Evans HJ: Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene 5: 1573–1579, 1990 Google Scholar
Mackay J, Steel CM, Elder PA, Forrest APM, Evans HJ: Allele loss on short arm of chromosome 17 in breast cancers. Lancet ii: 1384–1385, 1988 Google Scholar
Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 5794–5799, 1991 Google Scholar
McBride OW, Merry D, Givol D: The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83: 130–134, 1986 Google Scholar
Kim J-H, Takahashi T, Chiba I, Park J-G, Birrer MJ, Roh JK, De Lee H, Kim J-P, Minna JD, Gazdar AF: Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 83: 938–943, 1991 Google Scholar
Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T, Terada M: p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51: 5800–5805, 1991 Google Scholar
Murakami Y, Hayashi K, Hirohashi S, Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520–5525, 1991 Google Scholar
Davidoff AM, Kerns B-JM, Iglehart D, Marks JR: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51: 2605–2610, 1991 Google Scholar
Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420–427, 1988 Google Scholar
Hensel CH, Xiang RH, Sakaguchi AY, Naylor SL: Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Oncogene 6: 1067–1071, 1991 Google Scholar
McGuire WL, De La Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–639, 1977 Google Scholar
Powell B, Garola RE, Chamness GC, McGuire WL: Measurement of progesterone receptor in human breast cancer biopsies. Cancer Res 39: 1678–1682, 1979 Google Scholar
Fisher ER, Redmond C, Fisher B: Histologic grading of breast cancer. In: Sommers SC, Rosen PP (eds) Pathology Annual. Appleton-Century-Crofts, Norwalk CT, 1980, pp 231–251 Google Scholar
Carbone D, Chiba I, Mitsudomi T: Polymorphism at codon 213 within the p53 gene. Oncogene 6: 1691–1692, 1991 Google Scholar
Ostrowski JL, Henry SL, Wright C, Henry JA, Hennessy C, Lennard TJW, Angus B, Horne CHW: p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J Pathol 164: 75–81, 1991 Google Scholar
Isola J, Visakorpi T, Holli K, Kallioniemi O-P: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84: 1109–1114, 1992 Google Scholar
Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH, Smith HS: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845–855, 1992 Google Scholar
Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200–206, 1993 Google Scholar
Davidoff AM, Herndon JE II, Glover NS, Kerns B-JM, Pence JC, Iglehart JD, Marks JR: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110: 259–264, 1991 Google Scholar
Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D: p53 expression in breast cancer. Int J Cancer 41: 178–183, 1988 Google Scholar
Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 253: 1233–1238, 1990 Google Scholar
Law JC, Strong LC, Chidambaram A, Ferrell RE: A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res 51: 6385–6387, 1991 Google Scholar
Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP: A variation in the structure of the proteincoding region of the human p53 gene. Gene 70: 245–252, 1988 Google Scholar
Mazars R, Spinardi L, BenCheikh B, Simony-Lafontaine J, Jeanteur P, Theillet C: p53 mutations occur in aggressive breast cancer. Cancer Res 52: 3918–3923, 1992 Google Scholar